ANPEP and breast carcinoma: Peptides like RGD18, NGR19–21, and p160 (VPWMEPAYQRFL)22–24 target a number of different receptors such as integrin, aminopeptidase N (or CD13) and keratin 1, respectively, overexpressed by breast cancer cells.